Pathophysiology and clinical management of polycystic kidney disease in women

Seminars in Nephrology

Volumn 19, Issue 2, 1999, Pages 123-132

  Wilson, Patricia D ^a   Guay Woodford, Lisa ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN ARTERY ANEURYSM; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENETIC COUNSELING; HUMAN; KIDNEY POLYCYSTIC DISEASE; LIVER POLYCYSTIC DISEASE; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION;

CARDIOVASCULAR DISEASES; CYSTS; DISEASE PROGRESSION; FEMALE; GENETIC COUNSELING; HUMANS; INTRACRANIAL ANEURYSM; LIVER DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0033063172     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gabow P: Autosomal dominant polycystic kidney disease. N Engl J Med 329:332-342, 1993
2. Sedman P, Bell PM, Manco-Johnson R, et al: Autosomal dominant polycystic kidney disease in childhood: A longitudinal study. Kidney Int 31:1000-1005, 1987
3. Dalgaard O: Bilateral polycystic disease of the kidneys. A follow-up of two hundred and eighty four patients and their families. Acta Med Scand 328:1-255, 1957 (suppl)
4. Ravine D, Gibson R, Walker R, et al: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343:824-827, 1994
5. Elzinga L, Bennett W: Miscellaneous renal and systemic complications of ADPKD including infection, in Watson M, Torres V, (eds): Polycystic Kidney Disease. 1996, Oxford, Oxford University Press, 1996, pp 483-499
6. Bennett W, Elizinga L, Groper T, Barry J: Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol 137:620-622, 1987
7. Umemasu J, Fujiwara M, Munemura C, et al: Effects of topical instillation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease. Clin Nephrol 39:140-143, 1993
8. Elashry O, Nakada S, Wolf J, et al: Laparoscopy for adult polycystic kidney disease: A promising alternative. Am J Kidney Dis 27:224-233, 1996
9. Chapman A, Gabow R: Hypertension in autosomal dominant polycystic kidney disease. Kidney Int 52:S71-S73, 1997 (suppl 61)
10. Pick G, Dudley I, Johnson A, et al: The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 4:1654-1660, 1994
11. Watson M, Macnico A, Allan P: Genetic markers for polycystic kidney disease and their implications for detection of hypertension. J Hypertens 4:40-41, 1986
12. Kanno Y, Suzuki H, Okada H, et al: Calcium channel blockers versus ACE inhibitors as antihypertensives in polycystic kidney disease. Q J Med 89:65-70, 1996
13. Chapman A, Johnson A, Gabow P: Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: How to diagnose and who to screen. Am J Kidney Dis 22:526-531, 1993
14. Pirson Y, Chauveau D: Intracranial aneurysms in autosomal dominant polycystic kidney disease, in Watson M, Torres V, (eds): Polycystic Kidney Disease. Oxford, Oxford University Press, 1996, pp 530-547
15. Gabow P, Johnson A, Kaehny W, et al: risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11:1033-1037, 1990
16. Torres V: Polycystic liver disease, in Watson M, Torres V, (eds): Polycystic Kidney Disease. Oxford, Oxford University Press, 1996, pp 500-529
17. Chapman A, Johnson A, Gabow P: Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5:1178-1185, 1994
18. Multinovic J, Fialkow P, Agodoa L, et al: Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease. Obstet Gynecol 61:566-570, 1983
19. Wilson PD, Falkenstein D: The pathology of human renal cystic disease, in Dodd S, (ed): Current Topics in Pathology. Heidleberg, Springer-Verlag, 1995, pp 1-50
20. Devuyst O, Burrow CR, Smith BL, et al: Expression of aquaporins 1 and 2 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am J Physiol 271:F169F183, 1996
21. Wilson PD: Pathogenesis of polycystic kidney disease: Altered cellular function, in Watson M, Torres V, (eds): Polycystic Kidney Diseases. Oxford, Oxford Medical Publications, 1996, pp 125-163
22. Chatterjee S, Shi W, Wilson PD, et al: Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease. J Lipid Res 37:1334-1344, 1996
23. Kuo N, Norman JT, Wilson PD: Acidic FGF regulation of hyperproliferation of fibroblasts in human autosomal dominant polycystic kidney disease. Biochem Mol Med 61:178-191, 1997
24. Woo D: Apoptosis and loss of renal tissue in polycystic kidney disease. N EngI J Med 333:18-25, 1995
25. Wilson PD: Epithelial cell polarity and disease. Am J Physiol 272:F1-F9, 1997
26. Mangoo-Karim R, Uchic ME, Grant M, et al: Renal epithelial fluid secretion and cyst growth: The role of cyclic AMP. FASEB J 3:2629-2632, 1989
27. Avner ED, Sweeney W, Nelson WJ: Abnormal sodium pump distribution during renal tubulogenesis in congenital murine polycystic kidney disease. Proc Natl Acad Sei USA 89: 7447-7451, 1992
28. Ogbom MR, Sareen S, Tomobe K, et al: Renal tubule Na,K-ATPase polarity in different animal models of polycystic kidney disease. J Histochem Cytochem 43:785-790, 1995
29. Norman JT, Wilson PD: Abnormal matrix metalloproteinase (MMP) regulation in human autosomal dominant polycystic kidney disease (ADPKU). J Am Soc Nephrol 4:819,1993 (abstr)
30. Hartz PA, Wilson PD: Functional defects in lysosomal enzymes in autosomal dominant polycystic kidney disease (ADPKD): Abnormalities in synthesis, molecular processing, polarity and secretion. Biochem Mol Med 60:8-26, 1997
31. Murray SL, Grubman SA, Perrone RD, et al: Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease. Connect Tissue Res 33:249-256, 1996
32. Wilson PD, Gotti L, Burrow CR: Expression of the beta-2 isoform of Na,K-ATPase during human renal development and in polycystic kidney disease. Mol Biol Cell 4:34, 1993 (abstr)
33. The European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes for a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:882-894, 1994
34. The International Polycystic Kidney Disease Consortium: Polycystic kidney disease: The complete structure of the PDK1 gene and its protein. Cell 81:289-298, 1995
35. Ward CJ, Turley H, Ong AC, et al: Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sei USA 93:1524-1528, 1996
36. Geng L, Segal Y, Peissel B, et al: Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 98:2674-2682, 1996
37. Sandford J: Fourth European Workshop on PKD. Leiden, 1997
38. Arnould T, Kim E, Tsiokas L, et al: The polycystic kidney disease 1 gene product mediates protein kinase C alphadependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1. J Biol Chem 273:6013-6018, 1998
39. Peral B, Gamble V, Strong C, et al: Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach. Am J Hum Genet 60:1399-1410, 1997
40. Parfrey P, Bear J, Morgan J, et al: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323:1085-1090, 1990
41. Mochizuki T, Wu G, Hayashi T, et al: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
42. Tsiokas L, Kim E, Arnould T, et al: Homo- and heterodimeric interactions between the gene products ofPKDl and PKD2. Proc Natl Acad Sei USA 94:6965-6970, 1997
43. Nauta J, Goedbloed MA, Luider TM, et al: The Han: SPRD rat is not a genetic model of human autosomal dominant polycystic kidney disease type 1. Lab Anim 31:241-247, 1997